Ian Kingsbury, PhD
Director of Research
Ian Kingsbury has served as Do No Harm’s Director of Research since Spring 2023. In that role, he has taken the healthcare establishment to task over their lies about DEI and pediatric gender medicine.
Kingsbury has published several reports and his op-eds are regularly featured in leading national media outlets including The Wall Street Journal, Fox News, National Review, and the New York Post. His X account @PeerReReview is a valuable resource for debunking new “studies” from activists who try to pass off political agendas as research.
Kingsbury received his Ph.D. in education policy from the University of Arkansas and completed a postdoc at Johns Hopkins University.
Authored Content
Op-Ed
Doubt As a Badge of Honor
Do No Harm’s efforts to expose the scandal of sex-trait modification in gender non-conforming minors are getting noticed. In a recent manuscript published in…
Op-Ed
‘Gender-Affirming Care’ Is Increasingly Being Recognized as Unscientific
American medical associations are doubling down on their support of so-called gender-affirming care for children even as lawsuits mount and European countries reverse course. America’s public reckoning with the…
Report
Racial Concordance in Medicine: The Return of Segregation
Do patients have better health outcomes after seeing physicians of the same race? The ongoing reality of disparate health outcomes, with black patients typically experiencing worse outcomes than members of…
Op-Ed
Watch out! Antisemitism is soaring in US medicine
Antisemitism is now a full-blown crisis on the college campus, but it doesn’t end there: Similar hatred is increasingly widespread in the medical profession, where it’s even more dangerous. Doctors,…
Media Mention
Bad Medicine
A wave of open Jew-hatred by medical professionals, medical schools, and professional associations in the wake of the Hamas slaughter suggests that a field entrusted with healing is becoming a…
Report
The Anti-Semitic Double Standard of Medical Organizations
The radicalism observed on college campuses and in other elite spaces and institutions has or at least ought to invite soul-searching and fresh deliberation about where and why Jew-hatred is…
Op-Ed
Anti-racism supersedes actual medicine, endangers patients
Ibram X. Kendi’s gravy train could soon screech to a halt. The famous "anti-racist" professor is under intense public and institutional scrutiny after a Boston University investigation revealed that his "Center for…
Commentary
JAMA Once Again Favors Orthodoxy Over Rigor, Curiosity
A new study published in the Journal of the American Medical Association (JAMA) observes that black patients on dialysis are less likely than others to be placed on the kidney…
Op-Ed
A New Front in the War on Merit
Millions of academic studies are published each year. Some fundamentally alter the course of history, while others never even get cited. Those curious about the effect of specific researchers, papers,…
Op-Ed
See No Harm
Call it a match made in heaven. The Journal of the American Medical Association has a penchant for publishing non-rigorous research, and CNN has an insatiable appetite for…
Op-Ed
The Affirmative-Action Ruling Could Spell Trouble for the MCAT
Patients may suffer the painful consequences if the war against merit — and for racial discrimination — continues. The Supreme Court’s recent ruling against affirmative action in college admissions isn’t deterring…
Commentary
JAMA Beclowns Itself Yet Again
The Journal of the American Medical Association (JAMA) recently made waves by publishing junk science in one of their journals. Old habits die hard. Only one week later, they’re at…
Op-Ed
Birth of a Woke Myth: A new study on mass shootings is a prime example of public health’s growing penchant for policy-based evidence-making
Is there any limit to the degree to which “researchers” will discredit themselves to prove their woke bona fides? A new study published in JAMA Surgery suggests not. The study, “Association Between Markers…
Commentary
Taking Stock of a Milestone Moment in the Pediatric Gender Medicine Debate
A game-changer. That’s the undeniable reality of a letter published last week in the Wall Street Journal by 21 clinicians and researchers from nine countries. The authors, including some of…
Op-Ed
The Weak Evidence Behind ‘Gender-Affirming Care’ for Children
The Endocrine Society is ignoring the dangers that sex-change treatments pose to minors. Stephen Hammes’s response (Letters, July 5) to our op-ed (“The Endocrine…
Op-Ed
Selective Research from the AAMC
The Association of American Medical Colleges goes cherry-picking for data supporting “racial concordance” in patient treatment. Early last month, the Association of American Medical Colleges (AAMC)—the organization that oversees the…
Commentary
Trans activists aren’t ready to tell the truth about Europe
When will transgender activists tell the truth about Europeans reversing course on so-called “gender-affirming” care for kids? Several weeks ago, the Ohio House Public Health Committee heard testimony from critics…
Op-Ed
The Endocrine Society’s Dangerous Transgender Politicization
A federal court last week struck down an Arkansas law banning the provision of sex-change procedures—off-label “puberty blockers,” opposite-sex hormones and surgery—to minors. In the June 20 ruling, Judge James…
